Abbott Laboratories
Search results
AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives.
Apr 18, 2022 · AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.
It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and ulcerative colitis . It developed Skyrizi ($7.8 billion in 2023 revenues), an interleukin-23 (IL-23) inhibitor also used to treat autoimmune diseases.
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues...
May 7, 2024 · AbbVie discovers and delivers innovative medicines and solutions that enhance people’s lives.
AbbVie formed a new kind of enterprise – a biopharmaceutical company – with the stability, global scale, resources and commercial capabilities of a pharmaceutical company and the focus and culture of a biotech. Since the beginning, our mission hasn't wavered.
Innovating to meet patient needs. We partner with patients, patient organizations, caregivers and clinicians to ensure that individual experiences, perspectives, needs and priorities are part of our clinical development process. Oncology.
AbbVie Global; Menu. Our Company Explore Our Company About AbbVie Strategy At a Glance Recognition Positions and Views All Stories Our Science Explore Our Science Technologies & Platforms Clinical Trials Products Therapeutic Focus Areas AbbVie Medical Information Services opens in a new window; Community Explore Community Patient Associations ...
Jul 12, 2024 · AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Giant Cell Arteritis. Submissions are supported by the Phase 3 SELECT-GCA study demonstrating upadacitinib 15 mg with a 26-week steroid taper regimen achieved the primary endpoint of sustained remission from week 12... July 10, 2024.
May 7, 2024 · Find the answers you need or get in touch with us — AbbVie is here to help.
